|
WuXi PharmaTech (Cayman) Inc.
|
288 Fute Zhong Road
Waigaoqiao Free Trade Zone
Shanghai 200131
China |
| Tel: |
86/21-5046-1111 |
| URL: |
http://www.wuxipharmatech.com |
|
 |
| Primary Symbols & Exchanges: |
| WX - New York Stock Exchange |
|
|
| Primary Industry: |
| Biotechnology |
|
|
SIC Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activities are providing a broad and integrated portfolio of laboratory and manufacturing services in the drug discovery and development process to pharmaceutical and biotechnology companies. Its services are designed to help its customers address the bottleneck between the discovery of therapeutic targets and the testing of drug candidates in human clinical trials. Its operating in two segments: Laboratory Services, consisting of discovery chemistry, service biology, analytical, pharmaceutical development and process development services. Manufacturing is focusing on manufacturing of advanced intermediates and APIs. The Group operates in china, United States, Europe and Other countries. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on WuXi PharmaTech (Cayman) Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
